Sean Ainsworth is a director of Ocuphire Pharma Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ocuphire Pharma, Inc.
8 Jun 23
5
Ocuphire Pharma, Inc.
14 Feb 23
4
Ocuphire Pharma, Inc.
20 Oct 22
4
Ocuphire Pharma, Inc.
15 Jun 22
5
Ocuphire Pharma, Inc.
14 Feb 22
4
Ocuphire Pharma, Inc.
9 Jun 21
4
Ocuphire Pharma, Inc.
25 Nov 20
4
Ocuphire Pharma, Inc.
13 Nov 20
4
Ocuphire Pharma, Inc.
9 Nov 20
3
REXAHN PHARMACEUTICALS, INC.
9 Nov 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 23 | OCUP Ocuphire Pharma | Common Stock | Grant | Acquire A | No | No | 0 | 10,976 | 0.00 | 47,215 |
6 Jun 23 | OCUP Ocuphire Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 3.83 | 9,639 | 36.92 k | 9,639 |
27 Dec 22 | OCUP Ocuphire Pharma | Common Stock | Gift | Dispose G | No | No | 0 | 5,000 | 0.00 | 36,239 |